Tolerance and Efficiency of Paracetamol Subcutaneous Injection (TEPASC)

Centre Hospitalier Régional Metz-Thionville

Status: Completed

Conditions: Pain

Study type: Observational

Funder types: Other

Identifiers

NCT02884609

2014-02Obs-CHRMT

Details and patient eligibility

About

The purpose of this study is to evaluate the tolerance and the efficiency of subcutaneous administration of Paracetamol for patients in palliative care.

Full description

Subcutaneous administration is the most commonly used way for palliative care and geriatric service. A lot of drugs are recommended with subcutaneous administration, but their use is performed out of the Marketing Authorization, and fewer data exist about this practice in literature. Paracetamol is a grade 1 analgesic not currently recommended for subcutaneous injection, because of the lack of validated references. However this kind of administration is usually performed for Paracetamol in the French palliative care services related with its advantages for patients, as analgesic or antipyretic. The assumption of the study is that the use of paracetamol subcutaneously is possible with a good tolerance for hospitalized patients in palliative care service.

Enrollment: 160 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• older than 18 years old
• indication of paracetamol by subcutaneous injection, as an analgesic or an antipyretic

Exclusion criteria

• opposition to gather data patient
• subcutaneous administration of paracetamol during the last week before the inclusion of the patient